New Q&A released on the gradual roll-out of EUDAMED
New Q&A released on the gradual roll-out of EUDAMED
Tuesday, 26 November 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On November 21st, 2024, the Medical Device Coordination Group (MDCG) released a Q&A on the gradual roll-out of EUDAMED. This document provides a Q&A related to the implementation of the gradual roll-out of EUDAMED pursuant to the MDR and IVDR, as amended by Regulation (EU) 2024/1860.
Some key takeaways from the Q&A
The Q&A provides timelines and conditions for the activation and mandatory use of EUDAMED modules:
- Actor module,
- UDI/Device module,
- Notified bodies and certificates module,
- Market surveillance module,
- Post-market surveillance and Vigilance module,
- Clinical investigations/performance studies module.
It also clarifies the timelines for their implementation and the conditions under which stakeholders can or must use these modules. To enhance understanding, the document includes examples of transition periods and offers detailed guidance on managing obligations during the roll-out phase.
What does it mean to you?
This publication provides critical information for stakeholders in the medical device and in vitro diagnostic industries.
By aligning with the phased roll-out, stakeholders can proactively manage their responsibilities and contribute to the broader goals of harmonization and enhanced oversight within the EU’s medical device and diagnostics framework.
From idea to patient,
we've got you covered.
At QbD Group, we support every stage of your product’s journey - from development to market and beyond.
Ready to bring your ideas to life safely and compliantly?
Partner with us for success.
Discover more expert content
Previous
Regulatory Affairs
23 Feb 2024
EU Council Endorses Proposal to Amend IVDR and MDR Regulations
The Council of the European Union officially endorsed without any changes the proposal to amend...
Regulatory Affairs
30 Sep 2025
New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
23 Feb 2024
Proposed Amendments to IVDR and MDR: Transitional Provisions, EUDAMED Roll-Out, and Supply Chain Interruptions
EU Commission proposes IVDR & MDR amendments: Eudamed rollout, supply interruption reporting,...
Regulatory Affairs
6 Feb 2025
PMS Statutory Instrument + MHRA Guidance released (Great Britain)
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...
Regulatory Affairs
23 Feb 2024
EU Council Endorses Proposal to Amend IVDR and MDR Regulations
The Council of the European Union officially endorsed without any changes the proposal to amend...
Regulatory Affairs
30 Sep 2025
New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
23 Feb 2024
Proposed Amendments to IVDR and MDR: Transitional Provisions, EUDAMED Roll-Out, and Supply Chain Interruptions
EU Commission proposes IVDR & MDR amendments: Eudamed rollout, supply interruption reporting,...
Regulatory Affairs
6 Feb 2025
PMS Statutory Instrument + MHRA Guidance released (Great Britain)
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...
Regulatory Affairs
23 Feb 2024
EU Council Endorses Proposal to Amend IVDR and MDR Regulations
The Council of the European Union officially endorsed without any changes the proposal to amend...
Regulatory Affairs
30 Sep 2025
New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe